Author:
Di Xiangjie,Han Jie,Zou Sheng,Wei Xia,Huang Qingfei,Zhu Jin,Wang Yuanhua,Zhong Liu,Wang Qiwei
Subject
Organic Chemistry,Clinical Biochemistry,Pharmacology,Endocrinology,Molecular Biology,Biochemistry
Reference9 articles.
1. Farnesoid X receptor agonist for the treatment of liver and metabolic disorders: focus on 6-ethyl-CDCA;Fiorucci;Mini Rev. Med. Chem.,2011
2. Farnesoid X receptor targeting to treat nonalcoholic steatohepatitis;Adorini;Drug Disc. Today,2012
3. Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial;Neuschwander-Tetri;Lancet,2015
4. Bile acid derivatives as ligands of the farnesoid X receptor. Synthesis, evaluation, and structure− activity relationship of a series of body and side chain modified analogues of chenodeoxycholic acid;Pellicciari;J. Med. Chem.,2004
5. Obeticholic acid, a farnesoid X receptor agonist, improves portal hypertension by two distinct pathways in cirrhotic rats;Verbeke;Hepatology,2014
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献